Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve unaudited financial results ....
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech has informed the BSE that its Board of Directors will meet on Tuesday, August 12, 2025, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2025 (Q1 FY26). The company has also confirmed that the trading window for its securities has been closed from July 1, 2025, and will remain closed until 48 hours after the results are declared, in line with insider trading regulations. The filing is dated August 5, 2025, and signed by the Company Secretary.
This is a routine procedural filing ahead of quarterly results and contains no financial data or surprises. Shareholders should watch for the actual Q1 FY26 numbers on or after August 12, 2025, which could move the stock depending on performance versus expectations.